Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Calimmune presents preclinical results for its anti-HIV lentiviral vector gene therapy

May 31, 2013

First clinical study of Bionor Pharma's HIV vaccine candidate Vacc-C5 completes enrollment

May 29, 2013

Stribild receives European approval

May 29, 2013

Researchers at Merck Frosst Canada patent new agents for HIV infection

May 17, 2013

Improved pyrimidinediones for HIV infection described

May 15, 2013

Seattle Genetics and Spirogen prepare novel pyrrolobenzodiazepines

May 9, 2013

Yale University discloses new HIV reverse transcriptase inhibitors

May 8, 2013

FDA expands approval of efavirenz to patients as young as 3 months

May 6, 2013

Shionogi & Co. discloses new HIV integrase inhibitors

May 6, 2013

Ascletis Pharmaceuticals obtains rights to HIV drug in China

May 3, 2013

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...